Literature DB >> 29417165

Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.

Eileen Kasper1, Haemi Phaedra Schemuth1, Samantha Horry1, Sonja Kinner2.   

Abstract

BACKGROUND: Signal increase on T1-weighted magnetic resonance imaging (MRI) in the dentate nucleus has been reported in adults after multiple injections of gadolinium-based contrast agents. Linear contrast agents are more prone to cause this increase. Studies in children are still rare and focus mostly on the analysis of one single agent.
OBJECTIVE: To compare signal intensity chances in children after more than four injections of either only linear or only macrocyclic contrast agents.
MATERIALS AND METHODS: Seventy children (examined from October 2001 to February 2016) were included in this retrospective study. Signal intensities in the dentate nucleus and pons were measured on non-enhanced T1-weighted images from the first and last MRI scans. A two-sample t-test compared the dentate nucleus-to-pons signal intensity ratio differences for linear versus macrocyclic gadolinium-based contrast agent applications and also the number of applications (4-8, 9-12 or >12). Patients' charts were analysed to evaluate potentially associated neurological symptoms.
RESULTS: Patients had contrast-enhanced MRI using either only linear (n=16) or only macrocyclic (n=54) gadolinium-based contrast agents. In patients with >12 injections, dentate nucleus-to-pons signal intensity ratio was statistically different concerning the contrast agent class (0.16±0.125 for macrocyclic vs. 0.0005±0.13 for linear agents). For linear agents, a statistically significant increase was found between 4-8 injections (-0.051±0.087) and >12 injections (0.16±0.125). No neurological symptoms were recorded in patients with signal changes.
CONCLUSION: Multiple injections of linear gadolinium-based contrast agents lead to a signal increase of the dentate nucleus in children. Signal intensity increases depend on the number of injections of linear contrast agents.

Entities:  

Keywords:  Brain; Children; Dentate nucleus; Gadolinium deposition; Gadolinium-based contrast agents; Pons; Signal intensity ratio

Mesh:

Substances:

Year:  2018        PMID: 29417165     DOI: 10.1007/s00247-018-4080-5

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  26 in total

1.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

2.  No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.

Authors:  Alexander Radbruch; Robert Haase; Pascal J Kieslich; Lukas D Weberling; Philipp Kickingereder; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2016-12-07       Impact factor: 11.105

3.  Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy.

Authors:  Carlo Cosimo Quattrocchi; Carlo Augusto Mallio; Yuri Errante; Vincenzo Cirimele; Luciano Carideo; Antonella Ax; Bruno Beomonte Zobel
Journal:  Invest Radiol       Date:  2015-07       Impact factor: 6.016

4.  Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.

Authors:  Alexander Radbruch; Robert Haase; Philipp Kickingereder; Philipp Bäumer; Sebastian Bickelhaupt; Daniel Paech; Wolfgang Wick; Heinz-Peter Schlemmer; Angelika Seitz; Martin Bendszus
Journal:  Radiology       Date:  2017-03-08       Impact factor: 11.105

5.  Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.

Authors:  Nozomu Murata; Luis F Gonzalez-Cuyar; Kiyoko Murata; Corinne Fligner; Russell Dills; Daniel Hippe; Kenneth R Maravilla
Journal:  Invest Radiol       Date:  2016-07       Impact factor: 6.016

6.  T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.

Authors:  G K Schneider; J Stroeder; G Roditi; C Colosimo; P Armstrong; M Martucci; A Buecker; P Raczeck
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-22       Impact factor: 3.825

Review 7.  Are some agents less likely to deposit gadolinium in the brain?

Authors:  Alexander Radbruch
Journal:  Magn Reson Imaging       Date:  2016-09-11       Impact factor: 2.546

8.  MRI Brain Signal Intensity Changes of a Child During the Course of 35 Gadolinium Contrast Examinations.

Authors:  Jeffrey H Miller; Houchun H Hu; Amber Pokorney; Patricia Cornejo; Richard Towbin
Journal:  Pediatrics       Date:  2015-11-16       Impact factor: 7.124

9.  Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.

Authors:  D R Roberts; A R Chatterjee; M Yazdani; B Marebwa; T Brown; H Collins; G Bolles; J M Jenrette; P J Nietert; X Zhu
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825

10.  Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.

Authors:  Donna R Roberts; Kenton R Holden
Journal:  Brain Dev       Date:  2015-09-04       Impact factor: 1.961

View more
  8 in total

1.  Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.

Authors:  A Luana Stanescu; Dennis W Shaw; Nozomu Murata; Kiyoko Murata; Joe C Rutledge; Ezekiel Maloney; Kenneth R Maravilla
Journal:  Pediatr Radiol       Date:  2020-01-27

Review 2.  Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.

Authors:  Einat Blumfield; David W Swenson; Ramesh S Iyer; A Luana Stanescu
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 3.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

Review 4.  Gadolinium retention - 5 years later….

Authors:  Jonathan R Dillman; Matthew S Davenport
Journal:  Pediatr Radiol       Date:  2020-01-23

5.  Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.

Authors:  Nathalie Fretellier; Agnès Granottier; Marlène Rasschaert; Anne-Laure Grindel; Fannie Baudimont; Philippe Robert; Jean-Marc Idée; Claire Corot
Journal:  Invest Radiol       Date:  2019-02       Impact factor: 6.016

6.  Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance.

Authors:  Neil Zaki; David Parra; Quinn Wells; Joshua D Chew; Kristen George-Durrett; Sumit Pruthi; Jonathan Soslow
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-03       Impact factor: 5.364

7.  Age-Related Changes of the Human Crystalline Lens on High-Spatial Resolution Three-Dimensional T1-Weighted Brain Magnetic Resonance Images In Vivo.

Authors:  Felix Streckenbach; Oliver Stachs; Sönke Langner; Rudolf F Guthoff; Felix G Meinel; Marc-André Weber; Thomas Stahnke; Ebba Beller
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

8.  Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.

Authors:  Alexander J Towbin; Bin Zhang; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2021-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.